India's Pharmaceutical Exports

Country Profile

United Kingdom

United Kingdom is one of India's largest pharmaceutical export destinations — $903M in FY 2025–26, with 1.7× growth over the past decade. Medicines accounts for 87% of shipments, with vaccines contributing $63K. The compound annual growth rate since FY2015 stands at 5.1%.

🇬🇧 #2 Destination · $903M · 1.7× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$903M
Exports FY2025–26 DGCIS
1.7×
Growth FY2015→2026
2.9%
Share of India Total
#2
Rank Among 178 Markets
5.1%
CAGR FY2015→2026
United Kingdom is one of India's largest pharmaceutical export destinations — $903M in FY 2025–26, with 1.7× growth over the past decade. Medicines accounts for 87% of shipments, with vaccines contributing $63K. The compound annual growth rate since FY2015 stands at 5.1%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $783M (86.7%) Medicine Ingredients $72.6M (8.0%) Surgical & Hospital Supplies $30.0M (3.3%) Traditional & Herbal $17.1M (1.9%) Vaccines $63K (0.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to United Kingdom in the RBI overseas direct investment dataset (2011–2026).